A Platform Approach to Manage Developability and Manufacturability Risks of Biologics Molecules

April 8, 2019

Presented at PEGS, Boston, MA, USA

We present a workflow system that enables systematic developability and manufacturability assessments, using both in silico and high throughput analytical confirmatory methods, over the entire biologics R&D process from initial discovery all the way to final candidate selection. We show use cases for mAbs and other complex multi/bispecific formats and discuss building predictive developability models utilizing this system. We also present the underlying molecule and task management needed for analytical organizations to accomplish this.

Back to list